Economic evaluation of health promotion: Friend or foe?

Australian and New Zealand Journal of Public Health

Volumn 22, Issue 2, 1998, Pages 247-253

  Richardson, Jeff ^a,b  

^a Centre for Health Program Evaluation   (Australia)

^b Centre for Health Evaluation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH PROGRAM; HEALTH PROMOTION; OUTCOMES RESEARCH; PATIENT CARE; RESOURCE ALLOCATION; WELFARE; WELLBEING;

EID: 0031924753     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1998.tb01182.x     Document Type: Article

References (44)

1. Public Health Mapping Project Team. National public health infrastructure and investment mapping project: stage 1. Canberra (ACT): Report to the Commonwealth Department of Health and Family Services. Public Health Mapping Steering Committee. 1977.
2. Drummond MF, Stoddart G, Torrance G, Methods for the Economic Evaluation of Healthcare Programs. New York: Oxford University Press. 1987.
3. McGuire A, Henderson J, Mooney G. The Economics of Health Care. London: Rutledge and Keegan Paul, 1988.
4. Richardson J. Economic assessment of healthcare. theory and practice. The Australian Economic Review 1991; 1st Quarter: 1-21.
5. Richardson J. Cook J. Cost utility analysis: New directions in setting healthcare priorities. Australian Health Review 1992; 15(2): 145-55.
6. Drummond MF. Principles of Economic Appraisal in Healthcare. Oxford Oxford Medical Publications, 1990.
7. Culyer AJ. The normative economics of healthcare finance and provision. In: McGuire, A, et al., eds. Providing healthcare: the economics of alternative systems of finance and delivery. New York: Oxford University Press, 1991.
8. Robinson JC. Philosophical origins of the economic evaluation of life The Millbank Quarterly 1986, 64(1): 133-55.
9. Olsen JA. On what basis should health be discounted. Health Economics 1993a; 12: 39-53.
10. Weinstein MC. Foundations of cost effectiveness analysis for health and medical practices. New England Journal of Medicine 1977, 296: 716-21.
11. Weinstein MC. Time preference studies in the health care context. Medical Decision Making 1993; 13(3): 218-19.
12. Cairns J. Valuing future benefits. Health Economics 1994; 3(4): 221-30
13. Olsen JA. Time preference for health gains, an empirical investigation. Health Economics 1993b, 2(3): 256-66.
14. Robinson JC. Philosophical origins of the social rate of discount in cost-benefit analysis. The Millbank Quarterly 1990, 68(2): 245-66.
15. Parsonage M, Newberger H Discounting and health benefits Health Economics 1992, 1(1): 71-75.
16. Broome J. Discounting the future, [discussion paper 93/343]. Department of Economics. Bristol (UK): University of Bristol. 1993
17. Glenwick DS, et al., On considering the unintended impact of evaluation: reactive distortions in program goals and activities Evaluation and Planning 1984; 7: 321-27
18. Ginsberg The dysfunctional side effects of quantitative indicator production: illustrations from mental healthcare. Evaluation and Program Planning 1984; 7: 1-12.
19. Crowley S, Dunt D, Day N. Cost effectiveness of alternative interventions for the prevention and treatment of coronary heart disease. Australian Journal of Public Health 1995; 19. 336-46.
20. Field K, Thorogood M, Silargy C, Normand C, et al Strategies for reducing coronary risk factors in primary care: which is most cost effective? British Medical Journal 1995; 310 1109-12.
21. Hall J, Heller RK, Dobson A, Lloyd OM, et al. SR. A cost effectiveness analysis of alternative strategies for the prevention of heart disease. Medical Journal of Australia 1988; 148: 273-77.
22. Walker S, Rosser R. Quality of Life Assessment Key Issues in the 1990's. Dordrecht: Kluwer Academic Publishers, 1993.
23. McDowell I, Newell C. Measuring Health A Guide to Rating Scales and Questionnaires New York: Oxford University Press, 1987.
24. Bowling A Measuring Disease. Bristol (UK): Open University Press, 1995.
25. Sintonen H. An approach to measuring and valuing health state. Social Science and Medicine 1981; 15c: 55-65.
26. Kaplan R, Anderson JP. The general health policy model: An integrated approach. In: Spilker, ed Qualiry of Life Assessment in Clinical Trials. New York Raven Press, 1990.
27. World Health Organisation. International classification of impairments, disabilities and handicaps. A manual of classification relating to the consequences of disease. Geneva: WHO. 1980.
28. Ware JE, Sherborne CD. The MOS36 short term health survey (SF36) 1 Conceptual framework and item selection. Medical Care 1992, 30. 473-83.
29. Sintonen H. The 15D measure of health related quality of life The feasibility, reliability and validity of its valuations system. Melbourne: Monash University, National Centre for Health Program Evaluation; 1994: Working Paper 42.
30. Kind P The EuroQol instrument: an index of health related quality of life. In: Spilker, B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. New : York. Lippincott Raven, 1996
31. Szabo S. The World Health Organisation Quaterly of Life (WHOQOL) assessment instrument. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. New York: Lippmcott Raven, 1996.
32. Hawthorne G, Richardson J. An Australian MAU/QALY instrument: Rationale and preliminary result's . Fairfield, Victoria: Centre for Health Program Evaluation. 1995: Working Paper 49.
33. Hawthorne G, Richardson J, Osborne R. McNeil H. The Australian quality of life (AQoL) instrument: initial validation. Fairfield. Victoria: Centre for Health Program Evaluation, 1997: Working Paper 66.
34. Feeny D, Torrance G, Furlong W. Health utilities index. In Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trial. New York: Lippincott Raven, 1996
35. Nord E, Richardson J, et al Maximising health benefits versus egalitarianism: an Australian survey of health issues. Social Science and Medicine 1994; 14(16): 1429-37.
36. Sen A. Rational fools, a critique of their behavioural foundations of economic theory, philosophy and public affairs. In: Hahn F, Hollis M, eds. Philosophy and Economic Theory. Oxford: Oxford University Press, 1977: 317-44.
37. Margolis H. Selfishness, altruism and rationality. Cambridge: Cambridge University Press, 1982.
38. Brennan G Irrational action, individual sovereignty and political process: why there is a coherent ment goods argument [unpublished paper]. Canberra: Australian National University, Economics Faculty, 1986.
39. Wagstaff A. QALYs and the equity-efficiency trade off. Health Economics 1991, 10(1): 21-42.
40. Williams A Intergenerational equity: an exploration of the "fair innings" argument'. Health Economics 1997; 6(2): 117-32
41. Nord E, Street A, Richardson J, Kuhse, Singer P. The significance of age and enduration of effect in social evaluation of health care. Health Care Analysis 1996; 4: 103-11.
42. van Doorslaer E. Wagstaff A Equity in the delivery of health care: Some international comparisons. Health Economics 1992, 11(3): 389-412.
43. Johnson D, Kenyon P. Forecasting and futurology. The Australian Economic Review 1993; 2nd Quarter: 4-18.
44. Segal L, Richardson J. Economic framework for allocative efficiency in the health sector. The Australian Economic Review 1994; 2nd Quarter: 89-98.